SCHEMBL25772840

SCHEMBL25772840

CCCCCCCCCCCCCCCCCCOC[C@@H](CCc1ccccc1)COP(=O)(O)OC[C@]1(C#N)CC[C@H](c2ccc3c(N)ncnn23)O1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.35
▸ GPR34 Q9UPC5 2/20 0.31
▸ P2RY10 O00398 1/20 0.31
▸ GPR174 Q9BXC1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25768624 0.86 POLRMT (0.41) POLRMT
SCHEMBL25770198 0.86 POLRMT (0.41) POLRMT
SCHEMBL25077145 0.86 POLRMT (0.41) POLRMT
SCHEMBL25077182 0.86 POLRMT (0.43) POLRMTGPR34P2RY10GPR174
SCHEMBL25766720 0.86 POLRMT (0.39) POLRMTP2RY10
SCHEMBL25770214 0.86 POLRMT (0.39) POLRMTP2RY10
SCHEMBL25765423 0.84 POLRMT (0.44) POLRMTGPR34P2RY10GPR174
SCHEMBL25772728 0.84 POLRMT (0.34) POLRMT
SCHEMBL25772844 0.84 MAPK14 (0.35) POLRMT
SCHEMBL25772807 0.83 POLRMT (0.35) POLRMTP2RY10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212199-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212199-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PHOSPHO1, SGMS1, SGMS2 POLRMT 266/4885GPR34 3403/4885P2RY10 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback